Health

Nestle CEO discusses impact of weight loss drugs on food industry

The meteoric rise of weight loss drugs means consumers' nutritional needs are "shifting" which provides new opportunities for food companies,…

2 years ago

Ancient Skull With Brain Cancer Preserves Clues to Egyptian Medicine

Fluctuating disease rates, innovative treatments and talk of “moonshots” in the White House may make cancer seem like a modern…

2 years ago

Digital health companies are launching programs around GLP-1s

Patent protection for Wegovy — Novo Nordisk's blockbuster weight loss drug, which contains the second generation GLP-1 active ingredient and…

2 years ago

An Editor Whose Business Is Fitness

Times Insider explains who we are and what we do and delivers behind-the-scenes insights into how our journalism comes together.Molly…

2 years ago

Neuralink competitor Precision Neuroscience testing human brain implant

Dr. Joshua Bederson places Precision Neuroscience's electrodes onto a brain.Ashley CapootAs the lights dimmed in an operating room at The…

2 years ago

Younger Adults Are Missing Early Warning Signs of Colon Cancer

Why It MattersColon and rectal cancer rates have risen among younger adults as rates have declined among older people, who…

2 years ago

Pfizer announces new cost cutting program

Exterior view of the Pfizer headquarters building in New York City on Jan. 29, 2023.Kena Betancur | Corbis News |…

2 years ago

Dr. Paul Parkman, Who Helped to Eliminate Rubella, Dies at 91

Dr. Paul D. Parkman, whose research was instrumental in identifying the virus that causes rubella and developing a vaccine that…

2 years ago

Hims & Hers weight loss adds compounded GLP-1 injections

Products of Hims & Hers displayed.Hims & HersDigital pharmacy startup Hims & Hers Health is introducing access to compounded GLP-1…

2 years ago

Study Suggests Waiting Longer Before Withdrawing Life Support

When a patient with a severe traumatic brain injury is comatose, in intensive care, unresponsive and hooked up to a…

2 years ago

This website uses cookies.